Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018

Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018

Summary

GlobalDatas clinical trial report, Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018" provides an overview of Opium (Opioid) Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Opium (Opioid) Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Opium (Opioid) Addiction Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Opium (Opioid) Addiction 30
Apr 13, 2018: Patient-Reported Outcomes Data on SUBLOCADE (Buprenorphine Extended-Release) Injection to be Presented as Late-Breaker at American Society of Addiction Medicine (ASAM) 49th Annual Conference 30
Feb 13, 2018: Naltrexone transdermal patch (Nalsyn) has patent granted in USA 30
Clinical Trial Profile Snapshots 32
Appendix 338
Abbreviations 338
Definitions 338
Research Methodology 339
Secondary Research 339
About GlobalData 340
Contact Us 340
Source 340

List Of Tables

List of Tables
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Region, 2018* 7
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Opium (Opioid) Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Opium (Opioid) Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Opium (Opioid) Addiction Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Opium (Opioid) Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
Opium (Opioid) Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Opium (Opioid) Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List Of Figures

List of Figures
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Opium (Opioid) Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Opium (Opioid) Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Opium (Opioid) Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Opium (Opioid) Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
Opium (Opioid) Addiction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14
Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Opium (Opioid) Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 339

Europe Tiotropium (CAS 186691-13-4) Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Tiotropium market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end

USD 3000 View Report

Asia Pacific Tiotropium (CAS 186691-13-4) Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Tiotropium market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the

USD 3000 View Report

Opium (Opioid) Addiction - Pipeline Review, H2 2018

Opium (Opioid) Addiction - Pipeline Review, H2 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Opium (Opioid) Addiction - Pipeline Review, H2 2018, provides an overview of the

USD 2000 View Report

Opium (Opioid) Addiction - Pipeline Review, H1 2018

Opium (Opioid) Addiction - Pipeline Review, H1 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Opium (Opioid) Addiction - Pipeline Review, H1 2018, provides an overview of the

USD 2000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available